Effect of Gender on Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Real-World Study
<b>Objective:</b> To evaluate the differences in overall survival (OS) and progression-free survival (PFS) between men and women with non-small-cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs) in second-line and later treatments. <b>Methods:</b> A ret...
Saved in:
| Main Authors: | Teresa Calleja-Chucla, Patricia Cordeiro González, Alejandro Martínez Pradeda, Sonia Pértega-Díaz, Luis Margusino-Framiñán, Silvia Antolín Novoa |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/13/2/437 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Does Pre-Existing Chronic Obstructive Pulmonary Disease Increase the Risk of Checkpoint Inhibitor Pneumonitis in Advanced/Metastatic Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors?
by: David Spillane, et al.
Published: (2025-04-01) -
Risk factors for checkpoint inhibitor pneumonitis in lung cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
by: Xiaoqing Zhou, et al.
Published: (2025-05-01) -
Application of Immune Checkpoint Inhibitors in Cancer
by: Zhijun Chen, et al.
Published: (2025-08-01) -
Myasthenia Gravis in Patients Treated With Immune Checkpoint Inhibitors
by: Abdulrahman Alghabban, MD, et al.
Published: (2025-05-01) -
Patterns of immune-related adverse events in patients treated with immune checkpoint inhibitors: a Brazilian real-world analysis
by: Maria Paula Furtado Santos, et al.
Published: (2022-12-01)